Kairos Pharma, LTD. (KAPA)

NYSE · Pharmaceutical Preparations · Inc. DE

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 1 signal for Kairos Pharma, LTD.. Most notable: 2026-07-22: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing material agreement
  2. Material 8-K filing
    Filed 8-K disclosing material agreement
  3. Material 8-K filing
    Filed 8-K disclosing director or officer change
  4. Material 8-K filing
    Filed 8-K disclosing material agreement

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2025-10-08Bhowmick NeilofficerA171,7560$0
2025-10-08Bae Hyun W.directorA19,0840$0
2025-10-08Murali RamachandranofficerA152,6720$0
2025-10-08Keyoung Hansoo MichaeldirectorA19,0840$0
2025-10-08Singhvi RahuldirectorA19,0840$0
2025-10-08Samuelson DougofficerA152,6720$0
2025-10-08Yu John SdirectorA190,8400$0
2025-09-16Bae Hyun W.directorA10,0000$0
2025-09-16Keyoung Hansoo MichaeldirectorA10,0000$0
2025-01-01Bhowmick NeilofficerA14,0000$0
2025-01-01Murali RamachandranofficerA14,0000$0
2025-01-01Yu John SdirectorA14,0000$0
2024-11-25Murali RamachandranofficerP2001.59$318
2024-11-22Samuelson DougofficerP2,5001.5$3,750
2024-11-20Yu John SdirectorP4,0001.44$5,760

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings